Cortical thinning is associated with disease stages and dementia in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 8, 2013, Pages 875-881

  Zarei, Mojtaba ^a,b   Ibarretxe Bilbao, Naroa ^c,d,e   Compta, Yaroslau ^d,f   Hough, Morgan ^g   Junque, Carme ^c,d   Bargallo, Nuria ^h   Tolosa, Eduardo ^d,f   Martí, Maria Jose ^f  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Institute for Cognitive Science Studies   (Iran)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^e UNIVERSITY OF DEUSTO   (Spain)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN SIZE; CAUDATE NUCLEUS; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); CORTICAL THINNING; DEMENTIA; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FUSIFORM GYRUS; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PARKINSON DISEASE; PATIENT CODING; POSTERIOR CINGULATE; PRECUNEUS; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SUPPLEMENTARY MOTOR AREA; TEMPORAL CORTEX;

EID: 84879909621     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304126     Document Type: Article

References (36)

1. Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-92. (Pubitemid 36314364)
2. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-44.
3. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
4. Braak H, Rub U, Steur EN Jansen, et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64:1404-10. (Pubitemid 40570509)
5. Ballard C, Ziabreva I, Perry R, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931-4. (Pubitemid 44967366)
6. Halliday G, Hely M, Reid W, et al. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008;115:409-15.
7. Compta Y, Parkkinen L, O'Sullivan SS, et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 2011;134(Pt 5):1493-505.
8. Ibarretxe-Bilbao N, Tolosa E, Junque C, et al. MRI and cognitive impairment in Parkinson's disease. Mov Disord 2009;24(Suppl 2):S748-53.
9. Ibarretxe-Bilbao N, Junque C, Marti MJ, et al. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. J Neurol Sci 2011;310:70-4.
10. Lyoo CH, Ryu YH, Lee MS. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Mov Disord 2010;25:496-9.
11. Jubault T, Gagnon JF, Karama S, et al. Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage 2011;55:462-7.
12. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012;33:2521-34.
13. Weintraub D, Dietz N, Duda JE, et al. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 2012;135(Pt 1):170-80.
14. Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011;68:1562-8.
15. Dickerson BC, Feczko E, Augustinack JC, et al. Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area. Neurobiol Aging 2009;30:432-40.
16. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131(Pt 4):1057-68. (Pubitemid 351499426)
17. Salat DH, Lee SY, van der Kouwe AJ, et al. Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 2009;48:21-8.
18. Ibarretxe-Bilbao N, Junque C, Tolosa E, et al. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009;30:1162-71.
19. Compta Y, Marti MJ, Ibarretxe-Bilbao N, et al. Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Mov Disord 2009;24:2203-10.
20. Compta Y, Ibarretxe-Bilbao N, Pereira JB, et al. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism Relat Disord 2012;18:941-7.
21. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39:165-72. (Pubitemid 23216938)
22. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-86. (Pubitemid 36656531)
23. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-55.
24. Fischl B, Sereno MI, Tootell RB, et al. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999;8:272-84.
25. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870-8. (Pubitemid 34852500)
26. Muller CM, de Vos RA, Maurage CA, et al. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 2005;64:623-8. (Pubitemid 40995277)
27. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-8. (Pubitemid 39302834)
28. Pellicano C, Assogna F, Piras F, et al. Regional cortical thickness and cognitive functions in non-demented Parkinson 's disease patients: a pilot study. Eur J Neurol 2012;19:172-5.
29. Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130(Pt 7):1787-98. (Pubitemid 47343805)
30. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008;23:998-1005.
31. Del Tredici K, Rub U, De Vos RA, et al. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-26. (Pubitemid 34533671)
32. Braak H, Muller CM, Rub U, et al. Pathology associated with sporadic Parkinson's disease - where does it end? J Neural Transm Suppl 2006;70:89-97. (Pubitemid 44622184)
33. Sabbagh MN, Adler CH, Lahti TJ, et al. Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 2009;23:295-7.
34. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009;73:1738-45.
35. Nopoulos PC, Aylward EH, Ross CA, et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 2010;40:544-54.
36. Salat DH, Buckner RL, Snyder AZ, et al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004;14:721-30. (Pubitemid 38856947) Diseases